Ding-An Mao

842 total citations
32 papers, 609 citations indexed

About

Ding-An Mao is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Ding-An Mao has authored 32 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Ding-An Mao's work include Neuroscience and Neuropharmacology Research (6 papers), Metabolism and Genetic Disorders (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Ding-An Mao is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Metabolism and Genetic Disorders (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Ding-An Mao collaborates with scholars based in China, United States and Thailand. Ding-An Mao's co-authors include Xiao‐Bo Liao, Ling‐Qing Yuan, Liqun Liu, Rongrong Cui, Lingjuan Liu, G. Liu, Liang Qin, Yang Liu, Yi Liang and Shanshan Wu and has published in prestigious journals such as Scientific Reports, Endocrinology and Frontiers in Immunology.

In The Last Decade

Ding-An Mao

29 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ding-An Mao China 12 309 213 89 85 76 32 609
Qiu-Hua Liang China 14 229 0.7× 104 0.5× 65 0.7× 71 0.8× 46 0.6× 16 557
Lijun Chi Canada 19 554 1.8× 97 0.5× 92 1.0× 32 0.4× 95 1.3× 38 1.0k
Dong-Ho Kim South Korea 10 204 0.7× 82 0.4× 201 2.3× 29 0.3× 69 0.9× 18 664
Yue Xia China 15 224 0.7× 101 0.5× 60 0.7× 13 0.2× 93 1.2× 36 554
Samantha Moore United Kingdom 17 433 1.4× 61 0.3× 62 0.7× 33 0.4× 29 0.4× 33 885
Furu Wang China 13 278 0.9× 86 0.4× 35 0.4× 24 0.3× 28 0.4× 29 707
Leigh J. Ellmers New Zealand 15 399 1.3× 150 0.7× 136 1.5× 13 0.2× 44 0.6× 24 896
Christopher J. Pelham United States 18 330 1.1× 88 0.4× 77 0.9× 33 0.4× 19 0.3× 20 754
Hanbin Wang China 15 228 0.7× 72 0.3× 81 0.9× 20 0.2× 56 0.7× 54 582
Kevin C.M. Hermans Netherlands 10 344 1.1× 58 0.3× 83 0.9× 17 0.2× 34 0.4× 15 558

Countries citing papers authored by Ding-An Mao

Since Specialization
Citations

This map shows the geographic impact of Ding-An Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding-An Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding-An Mao more than expected).

Fields of papers citing papers by Ding-An Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding-An Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding-An Mao. The network helps show where Ding-An Mao may publish in the future.

Co-authorship network of co-authors of Ding-An Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Ding-An Mao. A scholar is included among the top collaborators of Ding-An Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding-An Mao. Ding-An Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bovornkitti, Somchai, et al.. (2025). Knowledge, Attitude, and Practice Toward Liver Fibrosis/Cirrhosis and Traditional Chinese Medicine Treatment Among Medical Staff. Journal of Evaluation in Clinical Practice. 31(1). e14261–e14261.
3.
Liu, Lingjuan, Liqun Liu, Lu Zhang, et al.. (2023). Case Report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus. Frontiers in Pediatrics. 10. 1004053–1004053. 4 indexed citations
5.
Liu, Liqun, et al.. (2022). Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants. Frontiers in Genetics. 13. 947886–947886. 3 indexed citations
6.
Huang, Peng, Lu Zhang, Li Tang, et al.. (2022). Analysis of Clinical and Genetic Characterization of Three Ataxia–Telangiectasia Pedigrees With Novel ATM Gene Mutations. Frontiers in Pediatrics. 10. 877826–877826. 1 indexed citations
7.
Liu, Lingjuan, Xing‐Fang Li, Jie Xiong, et al.. (2022). Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing. Frontiers in Nutrition. 9. 1028459–1028459. 22 indexed citations
8.
Huang, Peng, Li Tang, Lu Zhang, et al.. (2022). Identification of Biomarkers Associated With CD4+ T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis. Frontiers in Immunology. 13. 854848–854848. 17 indexed citations
9.
Xiong, Shiqiu, Yang Jia, Peng Huang, et al.. (2021). The First Case Report of X-Linked Sideroblastic Anemia With Ataxia of Chinese Origin and Literature Review. Frontiers in Pediatrics. 9. 692459–692459. 5 indexed citations
10.
Zhang, Lu, Jiao Cui, Lingjuan Liu, et al.. (2021). NLRC5: A Potential Target for Central Nervous System Disorders. Frontiers in Immunology. 12. 704989–704989. 11 indexed citations
11.
Liu, Lingjuan, Jie Xiong, Lu Zhang, et al.. (2021). The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis. Frontiers in Neurology. 12. 679430–679430. 5 indexed citations
12.
Wang, Aiping, Peng Huang, Lingjuan Liu, et al.. (2020). Novel NtA and LG1 Mutations in Agrin in a Single Patient Causes Congenital Myasthenic Syndrome. Frontiers in Neurology. 11. 239–239. 5 indexed citations
13.
J, Li, Lingjuan Liu, Jie Xiong, et al.. (2019). Clinicopathological characteristics of dysplastic teratomous neuroglia with anti-N-methyl-d-aspartate receptor encephalitis. Clinical Immunology. 210. 108271–108271. 2 indexed citations
14.
Xiong, Jie, Ding-An Mao, Lingjuan Liu, et al.. (2017). Early-onset epileptic encephalopathy with de novo SCN8A mutation. Epilepsy Research. 139. 9–13. 16 indexed citations
15.
Liu, Liqun, Jingyi Yu, Bao Zhang, et al.. (2017). Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine. Scientific Reports. 7(1). 40467–40467. 32 indexed citations
16.
Liu, Liqun, et al.. (2016). MicroRNA-34b mediates hippocampal astrocyte apoptosis in a rat model of recurrent seizures. BMC Neuroscience. 17(1). 56–56. 26 indexed citations
18.
Liao, Xiao‐Bo, Zhiyuan Zhang, Ke Yuan, et al.. (2013). MiR-133a Modulates Osteogenic Differentiation of Vascular Smooth Muscle Cells. Endocrinology. 154(9). 3344–3352. 116 indexed citations
19.
Cui, Rongrong, Yi Liang, Liang Qin, et al.. (2012). MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovascular Research. 96(2). 320–329. 140 indexed citations
20.
Cui, Rongrong, Ding-An Mao, Yi Lu, et al.. (2010). Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways. Amino Acids. 39(5). 1193–1200. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026